Toward a new prevention of suicide in schizophrenia.
World J Biol Psychiatry
; 5(4): 201-10, 2004 Oct.
Article
in En
| MEDLINE
| ID: mdl-15543514
Suicide is the primary cause of death among schizophrenic patients; follow-up studies suggested that 10-13% of schizophrenic patients die by suicide. Preventive measures based on early recognition of risk factors and the establishment of drug treatment protocols are no doubt of great help but have not resulted in a significant reduction of the number of suicides among these patients. Schizophrenia is a chronic disorder affecting all aspects of the individual's life. Prevention should therefore be addressed to various areas. This paper overviews studies dealing with major fields of interest in the prevention of suicide among patients with schizophrenia. The authors focus on the role of pharmacological treatment, psychosocial interventions and psychotherapy, the struggle against stigmatization and the role of GPs. Prevention of suicide among inpatients with schizophrenia is also analysed. It is concluded that those integrated strategies already in use and the implementation of less known interventions should constitute a more effective prevention of self-inflicted deaths among these patients.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Schizophrenia
/
Suicide
/
Antipsychotic Agents
/
Suicide Prevention
Type of study:
Etiology_studies
/
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
World J Biol Psychiatry
Journal subject:
PSIQUIATRIA
Year:
2004
Document type:
Article
Affiliation country:
Italy
Country of publication:
United kingdom